Dupilumab's impact on nasal citology: Real life experience after 1 year of treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dupilumab's impact on nasal citology: Real life experience after 1 year of treatment

Published:2024-07 Issue:4 Volume:45 Page:104275
ISSN:0196-0709
Container-title:American Journal of Otolaryngology
language:en
Short-container-title:American Journal of Otolaryngology

Author:

Gelardi Matteo,Giancaspro Rossana,Quaranta Vitaliano Nicola,La Gatta Emanuel,Ruzza Annamaria,Cassano Michele

Publisher

Elsevier BV

Reference43 articles.

1. The role of biologics in the treatment of chronic rhinosinusitis;Haloob;BioDrugs,2023

2. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP);Hardison;J Otolaryngol Head Neck Surg,2023

3. Two-year results of tapered dupilumab for CRSwNP demonstrates enduring efficacy established in the first 6months;van der Lans;Allergy,2023

4. Dupilumab-associated adverse events during treatment of allergic diseases;Kychygina;Clin Rev Allergy Immunol,2022

5. Dupilumab’s impact on blood parameters in nasal polyposis: 18-month follow-up in real life;Loperfido;J Immunol Res,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP